Is AMP a buy?

The financial sector has been firing but AMP has lagged.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Short-term hiccups can make for great buying opportunities.  The key of course is to be sure the hiccup is just that – short-term and not something more life threatening.

This very scenario could have recently just occurred at wealth manager AMP (ASX: AMP). When AMP updated the market at the end of June that it was experiencing some weakness in its wealth insurance division, the stock fell 15%. Since then other insurance market participants and commentators have highlighted some headwinds in the sector, however now that the dust has settled investors should be evaluating what the new information means for the long-term earnings power of AMP.

Given AMP's large market share, it won't escape these headwinds — as the downgrade has proved — however, in terms of the long-term profitability of one of Australia's largest financial service providers, it is unlikely to become a major inhibitor to its long-term earnings ability.

With that in mind, as the chart below shows, the recent dip in AMP's share price which has led the stock to underperform relative to its peers. This could have created an attractive opportunity for investors to purchase a blue chip company.

In the past 12 months the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) is up 21%; AMP, meanwhile, is up 20% which at first glance may appear to be an acceptable performance. However, in terms of relative performance, AMP is underperforming many in its peer group. For example, Perpetual (ASX: PPT) with its significant leverage to financial market has steamed over 75% higher, while IOOF (ASX: IFL) and Challenger (ASX: CGF) are both up over 30%

AMP

Source: Google Finance

Foolish takeaway

While Perpetual trades on a forecast price-to-earnings (PE) ratio of 23.2 (for financial year 2013 according to Morningstar) and IOOF trades on 17.4 times, AMP is trading on just 15.3 times. This looks comparatively more appealing and also comes with a dividend yield of over 5%.

In the market for high-yielding ASX shares? Get "3 Stocks for the Great Dividend Boom" in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading


Motley Fool contributor Tim McArthur owns shares in Perpetual.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »